HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Fazel Shokri Selected Research

Fazel Shokri Research Topics

Disease

7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2009 - 06/2005
6	Neoplasms (Cancer) 01/2009 - 07/2006
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2009 - 06/2005
3	Hemophilia A (Haemophilia) 05/2009 - 01/2005
2	Multiple Sclerosis 11/2009 - 03/2008
2	Diphtheria 06/2009 - 06/2007
2	Whooping Cough (Pertussis) 06/2009 - 06/2007
2	Tetanus 06/2009 - 06/2007
2	Wilms Tumor (Wilm's Tumor) 07/2008 - 02/2008
2	Leukemia 02/2008 - 07/2006
2	Residual Neoplasm 01/2007 - 07/2006
1	Infection 12/2009
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2009
1	Breast Neoplasms (Breast Cancer) 01/2009
1	Disease Progression 10/2008
1	Hepatitis B 06/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2008
1	Lipoma (Lipomata) 01/2008
1	Glioma (Gliomas) 01/2008
1	Brain Neoplasms (Brain Tumor) 01/2008
1	Rheumatoid Arthritis 01/2007
1	Pathologic Processes 01/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2005
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 06/2005
1	B-Cell Prolymphocytic Leukemia 06/2005
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2005
1	Lymphoma (Lymphomas) 06/2005
1	Hairy Cell Leukemia 06/2005
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2005
1	Multiple Myeloma 06/2005
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2005
1	Hepatocellular Carcinoma (Hepatoma) 01/2003

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 01/2009 - 07/2006
5	AntibodiesIBA 06/2009 - 01/2005
3	Messenger RNA (mRNA)IBA 06/2009 - 01/2008
3	Factor VIII (Coagulation Factor VIII)IBA 05/2009 - 01/2005
3	tyrosine receptor (receptor, tyrosine)IBA 09/2008 - 01/2007
3	Phosphotransferases (Kinase)IBA 09/2008 - 01/2007
2	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA 06/2009 - 06/2007
2	Fc Receptors (Fc Receptor)IBA 06/2009 - 11/2008
2	Pertussis VaccineIBA 06/2009 - 06/2007
2	ThymidineIBA 01/2009 - 01/2003
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 12/2009
1	Immunoglobulin Variable RegionIBA 12/2009
1	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2009
1	BM-cyclinIBA 12/2009
1	Interleukin-2 (IL2)IBA 11/2009
1	Interleukin-12 (IL 12)IBA 11/2009
1	AutoantibodiesIBA 05/2009
1	PeptidesIBA 05/2009
1	Nylons (Nylon)IBA 01/2009
1	Histocompatibility Antigens Class IIIBA 10/2008
1	Interleukin-1 (Interleukin 1)IBA 03/2008
1	CytokinesIBA 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)FDA Link 01/2008
1	8,11,14-Eicosatrienoic Acid (DHLA)IBA 01/2008
1	PPAR gammaIBA 01/2008
1	Retinoid X Receptor alphaIBA 01/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2008
1	OilsIBA 01/2008
1	Carrier Proteins (Binding Protein)IBA 01/2008
1	Epidermal Growth Factor Receptor (EGF Receptor)IBA 01/2008
1	gamma-Linolenic AcidIBA 01/2008
1	Interleukin-10 (Interleukin 10)IBA 08/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2007
1	VaccinesIBA 06/2007
1	Rheumatoid FactorIBA 01/2007
1	EnzymesIBA 01/2007
1	Proteins (Proteins, Gene)IBA 07/2006
1	CollagenIBA 06/2005
1	fibromodulinIBA 06/2005
1	EpitopesIBA 01/2005
1	T-2 Toxin (T 2 Toxin)IBA 01/2003
1	Trypan Blue FDA Link 01/2003
1	Neutral RedIBA 01/2003

Therapy/Procedure

4	Immunotherapy 06/2009 - 07/2006